Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: A prospective study

By Amadori D.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 1, 1997-03 ,pp. : 7-14

Springer Publishing Company

Access to resources Recommend Favorite

Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients - a prospective, comparative, non-randomised study

By Fiets W.E.   van Helvoirt R.P.   Nortier J.W.R.   van der Tweel I.   Struikmans H.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1081-1088

Elsevier

Access to resources Recommend Favorite

Primary systemic chemotherapy of breast cancer: indication and predictive factors

By Jinno Hiromitsu  

Breast Cancer, Vol. 18, Iss. 2, 2011-04 ,pp. : 74-79

Springer Publishing Company

Access to resources Recommend Favorite

Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy

By Gonzalez-Angulo A. M.   Liu S.   Chen H.   Chavez-MacGregor M.   Sahin A.   Hortobagyi G. N.   Mills G. B.   Do K.-A.   Meric-Bernstam F.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 909-916

Oxford University Press

Access to resources Recommend Favorite

DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: A pilot study

By Craciunescu Oana   Blackwell Kimberly   Jones Ellen   Macfall James   Yu Daohai   Vujaskovic Zeljko   Wong Terence   Liotcheva Vlayka   Rosen Eric   Prosnitz Leonard   Samulski Thaddeus   Dewhirst Mark  

International Journal of Hyperthermia, Vol. 25, Iss. 6, 2009-09 ,pp. : 405-415

Informa Healthcare

Access to resources Recommend Favorite